by Alyssa Hoehn, MD | Apr 19, 2026 | Eye Care, Research
The Short Version Valeda is the first FDA-authorized treatment for early-to-intermediate dry age-related macular degeneration (dry AMD). It’s a non-invasive light therapy. No injections, no dilation, no anesthesia. Four courses of nine short sessions over two...
Recent Comments